Mesenchymal Stem Cells in Regenerative Medicine:Mechanisms of action, sources, and delivery options

Neil Riordan, PhD, Founder of the Stem Cell Institute in Panama City, Panama will be speaking today, Wednesday, Feb 6 at the STEMSO International Stem Cell Society 2013 Conference in Fort Lauderdale, FL. The topic of Dr. Riordan's discussion will be "Mesenchymal Stem Cells in Regenerative Medicine:Mechanisms of action, sources, and delivery options" The theme [...]

2013-02-06T15:07:38+00:00February 6th, 2013|Adult Stem Cells, neil riordan, News, Stem Cell Research|

Multiple Sclerosis Radio – “Stem cells are your body’s natural healing mechanism” – Neil Riordan PhD

For anyone who missed Dr. Riordan's talk on MS Radio yesterday, below is a link to the replay. Did you know that by age 30, 96% of the mesenchymal stem cells are gone from a person's bone marrow? Why is MS a disease of the immune system? How can an automated machine analyze a sample [...]

Patients beware: “Point of care” fat stem cell separation and counting kits inaccurate and not US FDA approved for humans.

An informative paper by Mary Pat Moyer, PhD detailing why "same-day" fat stem cell kits that are becoming more common in doctors' offices across the US can miscount "stem cells" by large factors leading to over estimation of stem cell counts by as much as 20 times or more. It also states, "no complete harvest [...]

2013-01-22T23:15:25+00:00January 22nd, 2013|Adipose Stem Cells, Adult Stem Cells, News, Stem Cell Research|

Medistem Advances Type 1 Diabetes Stem Cell Technology Licensed From Yale

SAN DIEGO, CA -- (Marketwire) -- 09/12/12 -- Medistem Inc. (PINKSHEETS: MEDS) announced today completion of the first phase of a joint project with the Shumakov Research Center of Transplantology and Artificial Organs of the Russian Federation and its Russian and CIS licensee ERCell. The collaboration is based on using Endometrial Regenerative Cell (ERC) technology [...]

2012-09-13T17:37:45+00:00September 13th, 2012|Diabetes, News, Stem Cell Research|

Blood Stem Cells Permanently Damaged by Alcohol

Bone marrow stem cells are extremely sensitive to the primary by-product of alcohol, which causes permanent damage to their DNA claims researchers from the Medical Research Council (MRC) Lab of Molecular Biology. The research, which was conducted on mice, uncovers two mechanisms that normally control this type of damage; a protein group that recognizes and [...]

2012-08-28T17:39:57+00:00August 28th, 2012|Adult Stem Cells, News, Stem Cell Research|

Endometrial Stem Cells Yeild Postive Clinical Trial Results for Heart Disease

More progress reported on the treatment of heart disease with endometrial stem cells. Neil Riordan, PhD is one of the early pioneers of endometrial stem cell technology. Dr. Riordan is also the Founder and President of the Stem Cell Institute in Panama City, Panama. Positive Two-Month Data From RECOVER-ERC Congestive Heart Failure Trial SAN DIEGO, [...]

2012-06-06T17:50:59+00:00June 6th, 2012|Adult Stem Cells, Heart Disease, News, Stem Cell Research|

Adult Stem Cell Therapy Successfully Treats Spinal Cord Injury

An interesting spinal cord injury study was published last week. The Turkish researchers tested two types of stem cells on spinal cord injured mice. The two cell types were native bone marrow cells and cultured repair stem cells called Mesenchymal stem cells. Native bone marrow cells contain bone marrow forming stem cells as well as [...]

How Nasal Stem Cells Might Prevent Childhood Deafness

Medical News Today Sensorineural hearing loss is a type of deafness that generally begins in childhood, a condition that results from hearing cells in the cochlea losing their function. The hearing loss that occurs can often slow the development of the child and possibly cause speech and language problems to develop. Fortunately, Australian scientists have [...]

2012-02-13T20:28:23+00:00February 13th, 2012|Clinical Trials, News, Stem Cell Research|

Medistem Begins Phase II Clinical Trial for Heart Failure

Medistem Inc announced today treatment of 3 heart failure patients in the Non-Revascularizable IschEmic Cardiomyopathy treated with Retrograde COronary Sinus Venous DElivery of Cell TheRapy (RECOVER-ERC) trial. The trial is aimed at assessing safety and efficacy of the company's Endometrial Regenerative Cell (ERC) stem cell product in 60 heart failure patients who have no available [...]

2012-01-30T18:42:22+00:00January 30th, 2012|Adult Stem Cells, Heart Disease, News, Stem Cell Research|

Mechanism by Which Injured Tissue “Tells” Stem Cells to Leave Bone Marrow

Urao et al. Stem Cells. 2012 Jan 30. In addition to the established role of bone marrow derived stem cells in producing blood cells, an interesting aspect of these stem cells is to assist/accelerate tissue healing after injury. Perhaps the most studied example of this is in the situation of myocardial infarction (heart attack), in [...]

2012-01-30T18:40:24+00:00January 30th, 2012|Adult Stem Cells, News, Stem Cell Research|